The Conversation (0)
Ayurcann Holdings Corp. (CSE: AYUR) (the "Company" or "Ayurcann") a Canadian extraction company specializing in the processing of cannabis and hemp to produce oils and various derivative products, is pleased to announce that its common shares ("Common Shares") have been cross-listed for trading on the Frankfurt Stock Exchange ("FSE"), also known as Börse Frankfurt.
The Common Shares will be traded under the symbol "3ZQ0" (FSE: 3ZQ0). The market maker representing the Company in Germany is Steubing AG ("Steubing"), a licensed specialist at cross-listing foreign companies in the German markets, including the the Börse Frankfurt. Steubing operates on all German stock exchanges and has direct online access to around 50 international trading centres.
Igal Sudman, CEO of Ayurcann, commented: "We're excited to provide European investors with an opportunity to be a stakeholder and join our journey as we take significant strides towards becoming a leader in cannabis extraction and product manufacturing." Mr. Sudman continued, "Listing of our common shares on the Frankfurt Stock Exchange will provide the Company tremendous visibility to European investors that will only seek to match our appetite for growth over the coming months."
The listing of the Common Shares on the FSE will provide Ayurcann access to larger capital pools. Additionally, the listing is expected to broaden the shareholder base and lead to greater liquidity through increased trading activity in the Company's shares. The FSE is the world's third largest organized exchange-trading market in terms of turnover and dealings in securities. The exchange has more that 3,000 international companies listed on it.
Ayurcann continues to be listed on the Canadian Securities Exchange under the ticker symbol "AYUR".
For further information, please contact:
Igal Sudman, Chairman and Chief Executive Officer
Ayurcann Holdings Corp.
Tel: 905-492-3322 x30
Email: igal@ayurcann.com
Investor Relations:
Ryan Bilodeau
Tel: 416-910-1440
Email: ir@ayurcann.com
About Ayurcann Holdings Corp.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company's expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company's facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company's business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/93708
